CClinicalTrials.gg
CompletedNCT04274881Updated May 1, 2025

Surface Landmarks and C-length as Predictors of Depth of Right IJV Catheter Insertion: A TEE-Guided Study

An observational study in Catheterization, Central Venous, Echocardiography, Transesophageal and Anatomic Landmarks, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-01.

Sponsored by Ain Shams University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

The primary aim of this study is to derive a prediction rule to estimate the required length for placement of the CVC tip at the mid-point of the SVC from simple anatomical landmarks that are consistent with the known surface projections of the great veins. The accuracy of this rule will be examined using TEE and is intended for adult patients undergoing cannulation of the right IJV utilizing a middle approach. As a secondary aim, we will examine the performance of this suggested rule as contrasted with two other popular methods for estimation of the CVC length, the Peres formula and the C-length method.

Read the detailed description

Before induction of anesthesia

Three sets of measurements will be obtained for each participant before induction of anesthesia:

  1. Surface measurements: Three points will be placed on the skin using a non-erasable marker. Point A, at the apex of the triangle between the two heads of the sternomastoid. Point B, at the ipsilateral sternoclavicular joint. Point C, at the lower border of the right 2nd rib at its junction with the sternum. The distance between point A and point B and between point B and point C will be measured and added to each other to determine the catheter length expected to place the tip at the mid-SVC.
  2. Radiological measurements: On the plain posteroanterior (PA) chest X-ray (CXR), the distance from the tip of the transverse process of T1 to the tracheal bifurcation (C-length) will be measured.
  3. Using Peres' formuls (Height in cm/10), we will record the anti After induction of anesthesia After induction of anaesthesia, the TEE probe will be placed and a bicaval view will be displayed to visualize the right atrium-superior vena cava (RA-SVC) junction and the proximal (lower) part of the SVC at its entry into the right atrium (RA). The TEE probe will be manipulated to display the SVC as far as possible from its junction with the RA.

The right internal jugular vein (IJV) will be cannulated under ultrasound guidance using the Seldinger technique.

After puncture of the IJV a J-wire will be advanced through the trocar until the J-end of the guidewire is visualized at the RA-IJV junction via the TEE.

The CVC catheter will be passed over the guidewire to the RA-SCV junction. The guidewire will be removed and the catheter will then be retracted under TEE guidance until the tip in visualized at 3.0 cm above the RA-SVC junction as measured with the TEE cursor. If the distal (upper) portion of the SVC could not be visualized, the catheter would be retracted for 3 cm as guided by the 1-cm gradations on the CVC.

Post-operative After operation, plain PA CXR will be obtained at the intensive care unit (ICU) to verify the position of the CVC tip in relation to the carina.

Statistical Analysis:

The length of the catheter required to place the tip at the mid SVC will be regressed on the C-length or the surface distance to obtain a predictive equation. The accuracy of either equation will be assessed by estimation of the standard error of the estimate (SEest).

02

Conditions studied

  • Catheterization, Central Venous
  • Echocardiography, Transesophageal
  • Anatomic Landmarks
  • Radiography

Keywords

  • Surface landmarks
  • C-length
  • Central venous catheterization
  • Internal jugular vein
  • Prediction
  • Accuracy
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult subjects of either sex who are scheduled for elective cardiac surgery in whom echocardiography is indicated or recommended will be eligible.

Inclusion criteria

  • Adult subjects (age 18 years or older).
  • Elective cardiac surgery.
  • Echocardiography is indicated or recommended.

Exclusion criteria

Exclusion Criteria:

  • Previous cardiothoracic or neck surgery.
  • Previous radiotherapy on the neck or chest.
  • Intra-thoracic or neck mass lesions.
  • Deformity of the chest wall.
  • Anomalies of the great vessels.
  • Congenital heart disease.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (actual)
Patient registry
No

Interventions

  • ProcedureCatheterization of internal jugular vein

    The right internal jugular vein will be cannulated under transesophageal echocardiographic (TEE) guidance in order to place the catheter tip in the mid-SVC. The length of the catheter required to place the tip at the mid-SVC as guided by TEE will be regressed on the C-length or on the distance from the entry point to the surface point corresponding to the mid-SVC on the chest wall in order to obtain a predictive equation. The accuracy of either equation will be assessed by estimation of the standard error of the estimate (SEest).

    Also known as: Transesophageal echocardiography (to guide placement of central venous catheter tip at mid-SVC)

06

What researchers measure

Primary outcomes

  1. Accuracy of surface landmarks for prediction of CVC depth required to place the CVC tip at the mid-SVC.

    Difference between actual length required to place the CVC tip at the mid-SVC as guided by TEE and the distance from the entry point to the surface point corresponding to the mid-SVC on the chest wall.

    Time frame: Outcome will be assessed at completion of catheterization procedure

  2. Accuracy of C-length for prediction of CVC depth required to place the CVC tip at the mid-SVC.

    Difference between actual length required to place the CVC tip at the mid-SVC as guided by TEE and the C-length.

    Time frame: Outcome will be assessed at completion of catheterization procedure

07

Study locations

1 site
  • Ain Shams University Hospitals
    Cairo, 11517, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04274881
Lead sponsor
Ain Shams University
Responsible party
Sameh M. Hakim (Professor of Anesthesiology, Intensive Care and Pain Management, Ain Shams University) — Principal investigator
First posted
Feb 18, 2020
Start date
Oct 1, 2019
Primary completion
Sep 1, 2020
Completion
Dec 1, 2020
Last update
May 1, 2025

Study contacts

Sameh M Hakim, MD
study director · Ain Shamd University, Faculty of Medicine, Department of Anesthesiology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion